Stimulation of atherogenesis may be due to modifications of lipids, complement activation (enhancing the inflammatory response), endothelial dysfunction and hypercoagulation (elevated fibrinogen and plasminogen activator inhibitor) [48]. This evidence concerns the gene SERPINB2 and thrombophilia.